OBJECTIVE: The aim of the study is to determine the neuroglial differentiation potential of human Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) from preterm birth when compared to term delivery. STUDY DESIGN: The WJ-MSCs from umbilical cords of preterm birth and term controls were isolated and induced into neural progenitors. The cells were analyzed for neuroglial markers by flow cytometry, real-time polymerase chain reaction, and immunocytochemistry. RESULTS: Independent of gestational age, a subset of WJ-MSC displayed the neural progenitor cell markers Nestin and Musashi-1 and the mature neural markers microtubule-associated protein 2, glial fibrillary acidic protein, and myelin basic protein. Neuroglial induction of WJ-MSCs from term and preterm birth resulted in the enhanced transcription of Nestin and Musashi-1. CONCLUSIONS: Undifferentiated WJ-MSCs from preterm birth express neuroglial markers and can be successfully induced into neural progenitors similar to term controls. Their potential use as cellular graft in neuroregenerative therapy for peripartum brain injury in preterm birth has to be tested.
OBJECTIVE: The aim of the study is to determine the neuroglial differentiation potential of human Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) from preterm birth when compared to term delivery. STUDY DESIGN: The WJ-MSCs from umbilical cords of preterm birth and term controls were isolated and induced into neural progenitors. The cells were analyzed for neuroglial markers by flow cytometry, real-time polymerase chain reaction, and immunocytochemistry. RESULTS: Independent of gestational age, a subset of WJ-MSC displayed the neural progenitor cell markers Nestin and Musashi-1 and the mature neural markers microtubule-associated protein 2, glial fibrillary acidic protein, and myelin basic protein. Neuroglial induction of WJ-MSCs from term and preterm birth resulted in the enhanced transcription of Nestin and Musashi-1. CONCLUSIONS: Undifferentiated WJ-MSCs from preterm birth express neuroglial markers and can be successfully induced into neural progenitors similar to term controls. Their potential use as cellular graft in neuroregenerative therapy for peripartum brain injury in preterm birth has to be tested.
Authors: J Sanchez-Ramos; S Song; F Cardozo-Pelaez; C Hazzi; T Stedeford; A Willing; T B Freeman; S Saporta; W Janssen; N Patel; D R Cooper; P R Sanberg Journal: Exp Neurol Date: 2000-08 Impact factor: 5.330
Authors: Erica L Jackson; Jose Manuel Garcia-Verdugo; Sara Gil-Perotin; Monica Roy; Alfredo Quinones-Hinojosa; Scott VandenBerg; Arturo Alvarez-Buylla Journal: Neuron Date: 2006-07-20 Impact factor: 17.173
Authors: R C Vannucci; J R Connor; D T Mauger; C Palmer; M B Smith; J Towfighi; S J Vannucci Journal: J Neurosci Res Date: 1999-01-15 Impact factor: 4.164
Authors: Jun Lei; Wance Firdaus; Jason M Rosenzweig; Shorouq Alrebh; Ahmed Bakhshwin; Talaibek Borbiev; Ali Fatemi; Karin Blakemore; Michael V Johnston; Irina Burd Journal: Am J Obstet Gynecol Date: 2014-12-30 Impact factor: 8.661
Authors: S N Leow; Chi D Luu; M H Hairul Nizam; P L Mok; R Ruhaslizan; H S Wong; Wan Haslina Wan Abdul Halim; M H Ng; B H I Ruszymah; S R Chowdhury; M L C Bastion; K Y Then Journal: PLoS One Date: 2015-06-24 Impact factor: 3.240
Authors: Martin Mueller; Tim G A Wolfs; Andreina Schoeberlein; Antonio W D Gavilanes; Daniel Surbek; Boris W Kramer Journal: Mol Cell Pediatr Date: 2016-02-11